Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
arcomedlab
AddedFeb 16, 2024
UpdatedJun 18, 2026
arcomedlab

arcomedlab

Seed

arcomedLab, a division of Arcosystem Group, provides customized drug delivery and implant solutions.

HQ
Miami, FL, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in Miami, Florida, arcomedLab is a division of the Arcosystem Group dedicated to providing cutting-edge drug delivery and customized implant solutions. The company specializes in craniofacial implants, including cranial, chin, zygoma, angle, and orbit implants, utilizing advanced 3D/4D printing technologies. Their core mission is to restore life through innovative medical technology, with a vision of achieving perfection in medical implants. arcomedLab focuses on creating highly customized solutions using PEEK (polyether ether ketone) to replicate unique porosities and geometries.

Notable figures affiliated with arcomedLab include key researchers and engineers from the Arcosystem Group, who bring extensive expertise in medical device innovation. The company has garnered attention for its pioneering work in 3D/4D printing for medical applications, contributing significantly to the field of personalized medicine. Through its advanced implant solutions, arcomedLab has made a substantial impact on improving patient outcomes and advancing the capabilities of medical prosthetics.

arcomedlab - Similar Companies

Arcamed logo

Arcamed

arcamed.com

Zsfab logo

Zsfab

Carlsmed logo

Carlsmed

carlsmed.com

A.D.A.M. logo

A.D.A.M.

Quadric BioMed logo

Quadric BioMed

quadricbiomed.com

ARC Group Worldwide logo

ARC Group Worldwide

arcw.com

InPronto logo

InPronto

RevOrtho logo

RevOrtho

revortho.com

Ariste Medical logo

Ariste Medical

Limber Prosthetics and Orthotics logo

Limber Prosthetics and Orthotics

Active Implants logo

Active Implants

activeimplants.com

OsseoPrint 3D logo

OsseoPrint 3D

osseoprint3d.com

Braces On Demand logo

Braces On Demand

bracesondemand.com

ActivArmor logo

ActivArmor

activarmor.com

ALT logo

ALT

3dalt.com

arcomedlab - Quick Facts

Who are arcomedlab's competitors?

Companies similar to arcomedlab include Arcamed, Zsfab, Carlsmed and A.D.A.M..

When was arcomedlab founded?

arcomedlab was founded in 2018.

Where is arcomedlab's headquarters located?

arcomedlab's headquarters is located in Miami, FL, US.

When was arcomedlab's last funding round?

arcomedlab's most recent funding round was for $350k (USD) in February 2023.

How much has arcomedlab raised to-date?

As of Feb 23, 2023, arcomedlab has raised a total of $1.9M (USD).

How many employees does arcomedlab have?

arcomedlab has 14 employees as of Feb 4, 2024.

arcomedlab - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • 3d Printing
Geographic Exposure
  • Americas
Revenue
  • Transactional
Main Product
  • Drug Delivery
  • Implants
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities